CEBPB as a prognostic biomarker and its association with immune cells in clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is a highly aggressive malignancy with a poor prognosis. This study examines the expression, prognostic significance, and immune association of CCAAT/enhancer-binding protein beta (CEBPB) in ccRCC. RNA sequencing data from The Cancer Genome Atlas (TCGA) and Ge...

Full description

Bibliographic Details
Published in:	Biochemistry and Biophysics Reports
Main Authors:	Yaoqiang Ren, Min Wei, Quanfa Tian, Wenke Guo
Format:	Article
Language:	English
Published:	Elsevier 2025-12-01
Subjects:	ccRCC CEBPB Prognostic biomarker Immune infiltration
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405580825003188

Similar Items

Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma
by: Zhi Liu, et al.
Published: (2023-01-01)

Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis
by: Zezhong Yang, et al.
Published: (2024-02-01)

Identification of ferroptosis-related gene signatures as a novel prognostic model for clear cell renal cell carcinoma
by: Xiaoxiao Du, et al.
Published: (2025-04-01)

ZBP1 as a prognostic biomarker correlated with cell proliferation in clear cell renal cell carcinoma
by: Yuqing Zhang, et al.
Published: (2024-10-01)

Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
by: Liangsong Zhu, et al.
Published: (2019-07-01)

HROB as a novel prognostic biomarker associated with tumor immunity in clear cell renal cell carcinoma: A comprehensive analysis integrating bulk sequencing
by: Guixin Ding, et al.
Published: (2025-04-01)

Identification of prognostic RNA editing profiles for clear cell renal carcinoma
by: Weihong Chen, et al.
Published: (2024-07-01)

Prognostic factors and prognostic model of non-metastatic clear cell renal cell carcinoma
by: Juanyan Liao, et al.
Published: (2024-10-01)

KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma
by: Ke-Hao Pan, et al.
Published: (2023-09-01)

Unveiling FADS3 as a novel prognostic biomarker for tumor immunity in clear cell renal cell carcinoma through comprehensive RNA and single-cell sequencing
by: Zekun Xin, et al.
Published: (2025-04-01)

RGS19 is a novel prognostic biomarker for tumor immunity in clear cell renal cell carcinoma revealed through comprehensive bulk and single-cell sequencing analysis
by: Zhentao Lei, et al.
Published: (2025-03-01)

ARRB2 as a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma: Insights from integrated RNA and single-cell sequencing
by: Wenjun Meng, et al.
Published: (2025-08-01)

Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma
by: Yuxiong Jiang, et al.
Published: (2022-04-01)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
by: Shengxian Xu, et al.
Published: (2022-07-01)

GLIPR2 emerges as a potential predictor of prognosis for renal clear cell carcinoma, exhibiting substantial relevance with cellular metastasis and CD8+ T cell infiltration
by: Hong Zeng, et al.
Published: (2024-01-01)

Roles of cathepsin S expression levels on the prognosis and tumour microenvironment in clear cell renal cell carcinoma
by: Xiang Wang, et al.
Published: (2024-11-01)

GPD1L as a potential biomarker associated with Treg cell infiltration and lipid metabolism in clear cell renal cell carcinoma
by: Ming Yang, et al.
Published: (2025-08-01)

Identification of CENPW as a prognostic biomarker and potential therapeutic target for clear cell renal cell carcinoma
by: Haibing Xiao, et al.
Published: (2025-06-01)

Developing hypoxia and lactate metabolism-related molecular subtypes and prognostic signature for clear cell renal cell carcinoma through integrating machine learning
by: Jinhui Liu, et al.
Published: (2024-11-01)

AURKB: a promising biomarker in clear cell renal cell carcinoma
by: Bangbei Wan, et al.
Published: (2019-09-01)

Dynamic changes of SCGN expression imply different phases of clear cell renal cell carcinoma progression
by: Tuanjie Guo, et al.
Published: (2024-06-01)

BOP1: A pivotal prognostic biomarker in clear cell renal cell carcinoma uncovered through integrated bulk and single-cell sequencing
by: Wenyu Wang, et al.
Published: (2025-04-01)

Prognostic significance of systemic immunoinflammatory biomarkers in patients with clear cell renal cell carcinoma: a retrospective multicenter analysis
by: Danlei Chen, et al.
Published: (2025-08-01)

TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients’ survival
by: Xiao W, et al.
Published: (2018-11-01)

Prognostic biomarker and clinical significance of PLOD gene family in clear cell renal cell carcinoma
by: Xuan Shang, et al.
Published: (2025-10-01)

PLAC8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma
by: Xu Sun, et al.
Published: (2023-10-01)

A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs
by: Zuhu Yu, et al.
Published: (2023-03-01)

Cancer-Associated Fibroblast-Derived FGF7 Promotes Clear Cell Renal Cell Carcinoma Progression and Macrophage Infiltration
by: Man Jia, et al.
Published: (2024-11-01)

Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma
by: Daniel A. Mohl, et al.
Published: (2023-04-01)

Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma
by: Qinfan Yao, et al.
Published: (2023-06-01)

STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma
by: Jiyue Wu, et al.
Published: (2022-11-01)

EPHX2 overexpression deters the advancement of clear cell renal cell carcinoma via lipid metabolism reprogramming
by: Bo Guan, et al.
Published: (2025-06-01)

SERPINE1 and its co-expressed genes are associated with the progression of clear cell renal cell carcinoma
by: Lingyu Guo, et al.
Published: (2023-03-01)

Downregulation of GDF15 suppresses ferroptosis and predicts unfavorable prognosis in clear cell renal cell carcinoma
by: Dongliang Yang, et al.
Published: (2023-12-01)

AURKB promotes immunogenicity and immune infiltration in clear cell renal cell carcinoma
by: Weihao Liu, et al.
Published: (2024-07-01)

Exploring the prognostic implications of cuproptosis-associated alterations in clear cell renal cell carcinoma via in vitro experiments
by: Zhaoyu Xing, et al.
Published: (2024-07-01)

High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis
by: Pu Lei, et al.
Published: (2023-03-01)

CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
by: Can Chen, et al.
Published: (2024-02-01)

FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
by: Jiachen Liu, et al.
Published: (2024-11-01)

A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
by: Wangli Mei, et al.
Published: (2022-08-01)